Literature DB >> 34299319

Biocompatibility of Lithium Disilicate and Zirconium Oxide Ceramics with Different Surface Topographies for Dental Implant Abutments.

Susanne Jung1, Marco Maria Moser1, Johannes Kleinheinz1, Arndt Happe2,3.   

Abstract

Gingivafibroblasts were cultured on lithium disilicate, on zirconia dioxide, and on titanium with two different surface roughnesses (0.2 µm and 0.07 µm); Proliferation (MTT), Living/Dead staining, cytotoxicity (LDH), proliferation (FGF2), and inflammation (TNFα) were analyzed after 1 day and 21 days. Furthermore, alteration in cell morphology (SEM) was analyzed. The statistical analysis was performed by a Kruskal-Wallis test. The level of significance was set at p < 0.05. There were no distinct differences in cellular behavior between the tested roughness. There were slight differences between tested materials. Cells grown on zirconia dioxide showed higher cytotoxic effects. Cells grown on lithium disilicate showed less expression of TNFα compared to those grown on zirconia dioxide or titanium. These effects persisted only during the first time span. The results indicate that the two tested high-strength ceramics and surface properties are biologically suitable for transmucosal implant components. The findings may help clinicians to choose the most appropriate biomaterial as well as the most appropriate surface treatment to use in accordance with specific clinical dental applications.

Entities:  

Keywords:  dental implants; gingivofibroblasts; lithium disilicate; surface roughness; titanium; zirconium dioxide

Year:  2021        PMID: 34299319     DOI: 10.3390/ijms22147700

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  1 in total

1.  Impact of the material and sintering protocol, layer thickness, and thermomechanical aging on the two-body wear and fracture load of 4Y-TZP crowns.

Authors:  Felicitas Mayinger; Ramona Buser; Maximilian Laier; Lisa Marie Schönhoff; Matthias Kelch; Rüdiger Hampe; Bogna Stawarczyk
Journal:  Clin Oral Investig       Date:  2022-07-15       Impact factor: 3.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.